ConMed has been granted a patent for a uterine manipulator device comprising an elongated cannulated tube, a cervical cup, and an intrauterine balloon. The device allows for precise manipulation during gynecological procedures. GlobalData’s report on ConMed gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights ConMed Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on ConMed, Surgical robots was a key innovation area identified from patents. ConMed's grant share as of January 2024 was 58%. Grant share is based on the ratio of number of grants to total number of patents.

Uterine manipulator device with cannulated tube and cervical cup

Source: United States Patent and Trademark Office (USPTO). Credit: ConMed Corp

A recently granted patent (Publication Number: US11877772B2) discloses a uterine manipulator device designed to facilitate medical procedures. The device comprises an elongated cannulated tube, a cervical cup with a hole for the tube to pass through, and an intrauterine balloon that can be retained on a mechanism by being angled away from the longitudinal axis. Additionally, the device may include a vaginal cup to maintain pneumoperitoneum, a locking assembly, a handle with an inflation valve for the balloon, and a retention mechanism to prevent detachment of the cervical cup.

The patent claims detail various aspects of the uterine manipulator device, including the design of the cervical cup, the configuration of the intrauterine balloon, and the additional components such as the vaginal cup and locking assembly. The inclusion of a retention mechanism, handle with inflation valve, and specific positioning of components on the elongated cannulated tube are highlighted as key features of the device. These features aim to enhance the effectiveness and usability of the device during medical procedures involving uterine manipulation.

To know more about GlobalData’s detailed insights on ConMed, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.